Literature DB >> 1063127

Virus-induced osteosarcoma in rats.

A A Czitrom, K P Pritzker, F Langer, A E Gross, S C Luk.   

Abstract

An experimental model for osteosarcoma was developed in which, after Moloney murine sarcoma virus was injected into the tibial marrow space of three strains of inbred neonatal rats, a highly malignant neoplasm arose within ten days. This tumor was readily maintained in tissue culture and was transplantable to adult rats. It arose in the metaphyseal marrow of several bones, was locally invasive, metastasized to the lungs, and histologically resembled osteosarcoma.

Entities:  

Mesh:

Year:  1976        PMID: 1063127

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  6 in total

Review 1.  Canine and murine models of osteosarcoma.

Authors:  Jessica Beck; Ling Ren; Shan Huang; Erika Berger; Kathleen Bardales; Joshua Mannheimer; Christina Mazcko; Amy LeBlanc
Journal:  Vet Pathol       Date:  2022-03-26       Impact factor: 3.157

2.  Biochemical characterization of a virus-induced osteosarcoma-like osseous lesion in vitro.

Authors:  J Schmidt; E I Closs; E Livne; V Erfle; M Silbermann
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

3.  Ultrastructure of telangiectatic osteosarcoma.

Authors:  A Roessner; H P Hobik; M Immenkamp; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1979-10       Impact factor: 4.553

4.  Ultrastructural cytology of human osteosarcoma cells.

Authors:  D Katenkamp; D Stiller; G Waldmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-12-12

5.  Virally induced periosteal osteogenesis in mice.

Authors:  K Włodarski; M Kobus; M Luczak; J Dołowy
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

6.  Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges.

Authors:  Wan I Wan-Ibrahim; Vivek A Singh; Onn H Hashim; Puteri S Abdul-Rahman
Journal:  Mol Med       Date:  2015-11-13       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.